Free Trial

Ross Acquisition Corp II (ROSS) Competitors

Ross Acquisition Corp II logo
$11.08 0.00 (0.00%)
As of 01/17/2025

ROSS vs. ABL, CTO, TINV, ALTI, GAMI, FPI, PBT, CHCT, GMRE, and VINP

Should you be buying Ross Acquisition Corp II stock or one of its competitors? The main competitors of Ross Acquisition Corp II include Abacus Life (ABL), CTO Realty Growth (CTO), Tiga Acquisition (TINV), AlTi Global (ALTI), GAMCO Investors (GAMI), Farmland Partners (FPI), Permian Basin Royalty Trust (PBT), Community Healthcare Trust (CHCT), Global Medical REIT (GMRE), and Vinci Partners Investments (VINP). These companies are all part of the "trading" industry.

Ross Acquisition Corp II vs.

Ross Acquisition Corp II (NYSE:ROSS) and Abacus Life (NASDAQ:ABL) are both unclassified companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations, community ranking and media sentiment.

In the previous week, Abacus Life had 3 more articles in the media than Ross Acquisition Corp II. MarketBeat recorded 3 mentions for Abacus Life and 0 mentions for Ross Acquisition Corp II. Abacus Life's average media sentiment score of 0.42 beat Ross Acquisition Corp II's score of 0.00 indicating that Abacus Life is being referred to more favorably in the news media.

Company Overall Sentiment
Ross Acquisition Corp II Neutral
Abacus Life Neutral

Abacus Life received 13 more outperform votes than Ross Acquisition Corp II when rated by MarketBeat users. Likewise, 92.86% of users gave Abacus Life an outperform vote while only 0.00% of users gave Ross Acquisition Corp II an outperform vote.

CompanyUnderperformOutperform
Ross Acquisition Corp IIOutperform Votes
No Votes
Underperform Votes
1
100.00%
Abacus LifeOutperform Votes
13
92.86%
Underperform Votes
1
7.14%

Abacus Life has a consensus target price of $14.30, suggesting a potential upside of 91.95%. Given Abacus Life's stronger consensus rating and higher possible upside, analysts clearly believe Abacus Life is more favorable than Ross Acquisition Corp II.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ross Acquisition Corp II
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Abacus Life
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17

Ross Acquisition Corp II has a net margin of 0.00% compared to Abacus Life's net margin of -11.65%. Abacus Life's return on equity of 12.88% beat Ross Acquisition Corp II's return on equity.

Company Net Margins Return on Equity Return on Assets
Ross Acquisition Corp IIN/A N/A N/A
Abacus Life -11.65%12.88%6.51%

Ross Acquisition Corp II has higher earnings, but lower revenue than Abacus Life.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ross Acquisition Corp IIN/AN/A$14.87MN/AN/A
Abacus Life$79.59M7.93$9.52M-$0.18-41.39

27.8% of Ross Acquisition Corp II shares are held by institutional investors. 76.4% of Ross Acquisition Corp II shares are held by company insiders. Comparatively, 79.2% of Abacus Life shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Abacus Life beats Ross Acquisition Corp II on 12 of the 15 factors compared between the two stocks.

Get Ross Acquisition Corp II News Delivered to You Automatically

Sign up to receive the latest news and ratings for ROSS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ROSS vs. The Competition

MetricRoss Acquisition Corp IIHolding Offices IndustryUnclassified SectorNYSE Exchange
Market CapN/A$444.94M$123.13M$19.88B
Dividend YieldN/A7.17%5.15%3.61%
P/E RatioN/A2.421.1634.48
Price / SalesN/A111.0013.9617.08
Price / CashN/A69.4091.8317.53
Price / BookN/A4.681.015.78
Net Income$14.87M$34.48M$1.73M$1.01B
7 Day PerformanceN/A0.84%-0.53%2.23%
1 Month PerformanceN/A23.27%23.81%4.72%
1 Year Performance1.19%27.01%29.04%18.80%

Ross Acquisition Corp II Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ROSS
Ross Acquisition Corp II
N/A$11.08
flat
N/AN/A$0.00N/A0.003High Trading Volume
ABL
Abacus Life
3.7979 of 5 stars
$7.11
+2.7%
$14.30
+101.1%
-37.9%$602.07M$102.41M-39.5082
CTO
CTO Realty Growth
2.2649 of 5 stars
$19.51
+2.0%
$21.00
+7.6%
+18.3%$584.83M$118.66M33.0730
TINV
Tiga Acquisition
N/A$16.74
-3.3%
N/A+97.6%$577.53MN/A0.00N/AHigh Trading Volume
ALTI
AlTi Global
1.4587 of 5 stars
$4.13
+2.2%
$9.00
+117.9%
-34.9%$577.48M$246.97M-2.36490Short Interest ↑
GAMI
GAMCO Investors
N/A$22.80
-2.1%
N/A+24.4%$553.11M$235.87M8.77170Gap Down
FPI
Farmland Partners
0.9839 of 5 stars
$11.42
+0.1%
N/A+2.4%$550.14M$58.34M40.7930News Coverage
Positive News
PBT
Permian Basin Royalty Trust
0.4054 of 5 stars
$11.77
+0.8%
N/A-19.9%$548.60M$37.74M15.09N/APositive News
CHCT
Community Healthcare Trust
1.4897 of 5 stars
$18.84
+0.5%
$21.25
+12.8%
-25.8%$532.08M$115.61M-209.3337
GMRE
Global Medical REIT
4.5715 of 5 stars
$7.77
+3.3%
$11.25
+44.8%
-22.4%$519.06M$136.39M-388.3130Short Interest ↑
VINP
Vinci Partners Investments
4.2189 of 5 stars
$9.45
+1.6%
$13.50
+42.9%
-9.2%$508.21M$567.43M15.24240

Related Companies and Tools


This page (NYSE:ROSS) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners